Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 1,885 | 558 | 370 | 94 | 1 |
| Cost of Goods | 1,133 | 577 | 482 | 190 | N/A |
| Gross Profit | 753 | -19 | -112 | -97 | 1 |
| Operating Expenses | 1,686 | 1,377 | 906 | 684 | 8,079 |
| Operating Income | -800 | -819 | -536 | -591 | -8,078 |
| Interest Expense | 197 | 89 | 41 | 7 | 0 |
| Other Income | 0 | 89 | 41 | 7 | 0 |
| Pre-tax Income | -997 | -819 | -536 | -591 | -8,078 |
| Net Income Continuous | -997 | -819 | -536 | -591 | -8,078 |
| Net Income | $-997 | $-819 | $-536 | $-591 | $-8,078 |
| EPS Basic Total Ops | -0.04 | -0.04 | -0.04 | -0.14 | -2.14 |
| EPS Basic Continuous Ops | -0.04 | -0.04 | -0.04 | -0.14 | -2.14 |
| EPS Diluted Total Ops | -0.04 | -0.04 | -0.04 | -0.14 | -2.14 |
| EPS Diluted Continuous Ops | -0.04 | -0.04 | -0.04 | -0.14 | -2.14 |
| EBITDA(a) | $-619 | $-639 | $-446 | $-791 | $-7,832 |